Cerebral vascular events with hyperhomocysteinemia. Controlling thromboembolic events with folates;Accident vasculaire cerebral avec hyperhomocysteinemie. Arret des accidents thromboemboliques sous folates

Presse Medicale

Volumn 26, Issue 27, 1997, Pages 1289-1291

  Candito, M ^a,c   Bedoucha, P ^a   Jambou, D ^a   Appert Flory, A ^a   Fisher, F ^a   Parrot Roulaud, F ^b   Bayle, J ^a   Van Obberghen, E ^a   Chatel, M ^a  

^a UNIVERSITY HOSPITAL OF NICE   (France)

^b BORDEAUX UNIVERSITY HOSPITAL   (France)

^c PASTEUR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; HOMOCYSTEINE; PROTHROMBIN; BLOOD CLOTTING FACTOR 5; METHYLENETETRAHYDROFOLATE DEHYDROGENASE;

ADULT; ARTICLE; CASE REPORT; CEREBROVASCULAR DISEASE; DRUG EFFICACY; FEMALE; GENE MUTATION; HUMAN; RISK FACTOR; THROMBOEMBOLISM; BLOOD; GENETICS; HOMOZYGOTE; LEG; METABOLISM; MUTATION; THROMBOSIS; VASCULARIZATION;

ADULT; FACTOR V; FEMALE; FOLIC ACID; HOMOCYSTEINE; HOMOZYGOTE; HUMANS; INTRACRANIAL EMBOLISM AND THROMBOSIS; LEG; METHYLENETETRAHYDROFOLATE DEHYDROGENASE (NADP); MUTATION; THROMBOSIS;

EID: 0031580615     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Bienvenu T, Ankri A, Chadefaux B, Kamoun P. Dosage de l'homocystéine plasmatique dans l'exploration des thromboses du sujet jeune. Presse Med 1991 ; 20:985-8.
2. Andersson A, Brattstrom L, Israelsson B, Isaksson A, Hamlett H, Hultberg B. Plasma homocysteine before and after methionine loading with regard to age, gender and menopausal status. Eur J Clin Invest 1991 ; 22:79-87.
3. Frosst P, Blom HJ, Milos R et al. A candidate genetic risk factor for vascular disease a common mutation in methyltetrahydrofolate reductase. Nature Gene 1995 ; 10:111-13.
4. Mandel H, Brenner B, Berant M et al. Coexistence of hereditary homocystinuria and factor V Leiden-effect on thrombosis. N Engl J Med 1996 ; 354:763-8.
5. Candito M, Bedoucha P, Mahagne MH, Scavini G, Chatel M. Total plasma homocysteine determination by liquid chromatography before and after methionine loading. Results in cerebrovascular disease. J Chromatogr B 1997 ; 692:213-16.
6. Chadefaux B, Kara Mostefa A, Thuillier L et al. Does the prevalent mutation 677C→T in the methylenetetrahydrofolate reductase gene account for hyperhomocysteinemia related to cardio vascular disease? J Inher Metab Dis 1996 ; suppl. 1:49.
7. Malinow MR. Homocysreine and arterial occlusive diseases. J Int Med 1994 ; 236:603-17.
8. Leclerc D, Goyette P, Rosenblatt S. Human methionine synthase αDNA cloning and identification of mutations in patients of the cbIG complementation group of folatecobalamin disorders. Hum Mol Genet 1996 ; 5:1859-65.
9. Brattstrom L, Israelsson B, Norrving B et al. Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment. Atherosclerosis 1990 ; 81:51-60.
10. Rozen R. Molecular genetic aspects of hyperhomocysteinemia and its relation to folic acid. Clin Invest 1996 ; 19:171-8.